Capillary zone electrophoresis-mass spectrometry (CZE-MS) is an advanced analytical technique that is being applied to the characterization of biopharmaceuticals such as proteins, monoclonal antibodies, vaccines, etc. This technique combines the separation power of CZE with the sensitive detection capability of MS and can be used to identify low concentrations of proteins and their variants, which is often a requirement for biopharmaceutical analysis. CD Formulation integrates cutting-edge CZE-MSE technology into our protein characterization technology platform to provide reliable analytical support for the development and characterization of your protein/peptide drugs to determine drug purity, structural integrity and charge heterogeneity and meet regulatory requirements.
CZE is an analytical chemistry technique that uses an electric field within a thin capillary filled with a buffer solution to separate ionic species based on their charge and size. CZE is characterized by high efficiency, high speed, and low sample and reagent consumption. Compared with liquid chromatography, CZE has extremely low carryover, relatively fast separation speed, and inexpensive instrumentation. CZE, coupled with mass spectrometry, provides a rapid, cost-effective analytical method to help researchers evaluate the quality, consistency, and stability of biopharmaceutical drugs during biopharmaceutical drug development.
Fig. 1 Schematic designs of the CZE-MS system. (Chen D, et al., 2023)
CZE-MS analysis is based on the separation power of electrophoresis and the sensitive detection capabilities of mass spectrometry. In CZE, an electric field is applied across a narrow capillary filled with an electrolyte solution. Charged proteins migrate through the capillary toward the electrode, and in the presence of the electric field, their migration rate is affected by their charge-to-size ratio (z/e). Smaller and more highly charged molecules migrate faster than larger or less charged molecules. As the analytes migrate, they form distinct zones based on their electrophoretic mobility. This separation occurs rapidly in the small volume of the capillary because of the high electric field strength that can be applied. The analytes exiting the capillary are ionized and analyzed by the mass spectrometer. By detecting the ions, the analytes can be identified and quantified based on their specific mass and abundance.
Thanks to decades of experience in supporting protein/peptide biopharmaceutical development and manufacturing using CZE-MS technology, our team of highly qualified experts offers a range of CZE-MS-related services to accelerate the implementation and success of your projects.
Our scientists will work with you to continuously optimize CZE-MS programs to support all stages of protein/peptide drug development and manufacturing - from early protein/peptide drug discovery to late-stage drug development and post-release testing under GMP.
Utilizing cutting-edge CZE-MS technology, we support the following protein/peptide characterization plans, including but not limited to:
CZE-MS is an effective tool for assessing the purity of protein drug formulations, with its ability to separate and analyze multiple protein variants simultaneously. Our scientists use this technology to accelerate the development of your project by identifying any impurities and degradation products that may affect drug safety and efficacy during the development and manufacturing of proteins and peptides.
PTMs can occur at every step of the manufacturing process. These modifications can affect the charge state of the molecule and impact the potency of the molecule. As a regulatory release assay, we utilize CZE-MS to identify these charge variants, particularly glycosylation, phosphorylation, and oxidation.
CZE is able to separate proteins based on their size and charge, providing valuable insights into the heterogeneity of protein drugs. This helps understand the distribution of different protein species in a therapeutic formulation, which is critical to ensuring consistent efficacy and safety.
CZE-MS can be used to quantify protein drugs. By calibrating the response of the mass spectrometer, our scientists can determine the concentration of specific protein variants in a complex mixture, enabling precise quantification to support quality control in biopharmaceutical manufacturing.
CZE-MS has become an important tool for comparing the structure and function of a reference biologic with its biosimilar. This comparison is critical for regulatory approval and ensuring that biosimilars provide equivalent therapeutic benefits. Our scientists use this tool to help you obtain detailed molecular characteristics of your protein samples, including their charge heterogeneity, molecular weight distribution, and glycosylation patterns, to gain insight into the similarities and differences between the reference biologic and the biosimilar.
In CZE-MS analysis, the analytes flowing out of CZE need to undergo a certain degree of ionization before entering the mass spectrometer for detection. To this end, our analytical laboratory is equipped with a variety of mass spectrometers with different ionization technologies to meet different analytical needs.
Published Data
Technology: CZE-MS/MS for HCP Detection
Journal: Electrophoresis.
IF: 2.744
Published: 2016
Results:
The authors developed a CZE-MS/MS method for the online detection of trace host cell protein impurities in recombinant therapeutics. Synthetic HCP samples were generated by spiking recombinant monoclonal antibodies at five concentration levels of 12 different protein standards, and calibration curves were prepared. After trypsin digestion of the proteins, the spiked protein digests were analyzed using a custom CZE-MS/MS system and ultra-performance liquid chromatography (UPLC)-MS/MS. The results showed that both methods detected all 12 proteins at a spiked level of approximately 100 ppm, but CZE-MS/MS consistently detected more peptides than RPLC-MS/MS for almost all concentrations of the proteins.
Fig. 2 Calibration curves for absolute quantification by CZE-MS and RPLC-MS. (Zhu G, et al., 2016)
CD Formulation aims to provide a powerful analytical tool for the separation, purification, and characterization of proteins and peptides. Please feel free to contact us if you are interested in our services. Learn how our CZE-MS technology can support the smooth implementation of your protein/peptide biopharmaceutical program.
References